Filed: 8/11/2025ACC: 0000950123-25-007478
📋 What this filing means
PATIENT SQUARE CAPITAL LP filed this quarterly 13F‑HR report disclosing 19 equity positions with a total reported market value of $277.39M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
19
Positions
$277.39M
Total AUM (reported)
22.13M
Total Shares
Allocation by class
SHS$140.65M50.7%
COM$58.47M21.1%
COM PAR $.01$36.11M13.0%
COM NEW$26.17M9.4%
SPONSORED ADR$15.99M5.8%
Portfolio Concentration
Top 3$192.74M69.5%
4–10$56.91M20.5%
11–25$27.73M10.0%
Top 3 weight
69.5%
Top 10 weight
90.0%
Voting Authority Distribution
Total shares with voting rights: 22.13M
Sole
Full voting authority
22.13M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole19
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings19
Rows:
ROIVANT SCIENCES LTD.
SOLEShares12.48M
TypeSH
Market value$140.65M
50.71%
Sole
12.48M
Shared
0.00
None
0.00
INSMED INC
SOLEShares358.80K
TypeSH
Market value$36.11M
13.02%
Sole
358.80K
Shared
0.00
None
0.00
ARGENX SE - ADR
SOLEShares29K
TypeSH
Market value$15.99M
5.76%
Sole
29K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS, INC.
SOLEShares1.35M
TypeSH
Market value$12.73M
4.59%
Sole
1.35M
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares1.02M
TypeSH
Market value$12.71M
4.58%
Sole
1.02M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX, INC.
SOLEShares817.70K
TypeSH
Market value$7.59M
2.74%
Sole
817.70K
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS, INC.
SOLEShares868.90K
TypeSH
Market value$6.54M
2.36%
Sole
868.90K
Shared
0.00
None
0.00
KYMERA THERAPEUTICS, INC.
SOLEShares140K
TypeSH
Market value$6.11M
2.20%
Sole
140K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS, INC.
SOLEShares113.46K
TypeSH
Market value$5.77M
2.08%
Sole
113.46K
Shared
0.00
None
0.00
SCHOLAR ROCK HOLDING CORPORATION
SOLEShares154K
TypeSH
Market value$5.45M
1.97%
Sole
154K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS, INC.
SOLEShares245.84K
TypeSH
Market value$4.93M
1.78%
Sole
245.84K
Shared
0.00
None
0.00
NURIX THERAPEUTICS, INC.
SOLEShares412.30K
TypeSH
Market value$4.70M
1.69%
Sole
412.30K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS, INC.
SOLEShares139.73K
TypeSH
Market value$4.65M
1.68%
Sole
139.73K
Shared
0.00
None
0.00
PHARVARIS N. V.
SOLEShares244.28K
TypeSH
Market value$4.30M
1.55%
Sole
244.28K
Shared
0.00
None
0.00
DISC MEDICINE, INC.
SOLEShares74K
TypeSH
Market value$3.92M
1.41%
Sole
74K
Shared
0.00
None
0.00
ALLOGENE THERAPEUTICS, INC.
SOLEShares2.63M
TypeSH
Market value$2.98M
1.07%
Sole
2.63M
Shared
0.00
None
0.00
GERON CORP
SOLEShares716K
TypeSH
Market value$1.01M
0.36%
Sole
716K
Shared
0.00
None
0.00
CIDARA THERAPEUTICS INC
SOLEShares15K
TypeSH
Market value$730.6K
0.26%
Sole
15K
Shared
0.00
None
0.00
VYNE THERAPEUTICS INC.
SOLEShares317.03K
TypeSH
Market value$523.1K
0.19%
Sole
317.03K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTD.SOLE | SHS | 12.48M | SH | $140.65M 50.71% | 12.48M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 358.80K | SH | $36.11M 13.02% | 358.80K | 0.00 | 0.00 |
ARGENX SE - ADRSOLE | SPONSORED ADR | 29K | SH | $15.99M 5.76% | 29K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS, INC.SOLE | COM NEW | 1.35M | SH | $12.73M 4.59% | 1.35M | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 1.02M | SH | $12.71M 4.58% | 1.02M | 0.00 | 0.00 |
OCULAR THERAPEUTIX, INC.SOLE | COM | 817.70K | SH | $7.59M 2.74% | 817.70K | 0.00 | 0.00 |
CULLINAN THERAPEUTICS, INC.SOLE | COM | 868.90K | SH | $6.54M 2.36% | 868.90K | 0.00 | 0.00 |
KYMERA THERAPEUTICS, INC.SOLE | COM | 140K | SH | $6.11M 2.20% | 140K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS, INC.SOLE | COM | 113.46K | SH | $5.77M 2.08% | 113.46K | 0.00 | 0.00 |
SCHOLAR ROCK HOLDING CORPORATIONSOLE | COM | 154K | SH | $5.45M 1.97% | 154K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS, INC.SOLE | COM | 245.84K | SH | $4.93M 1.78% | 245.84K | 0.00 | 0.00 |
NURIX THERAPEUTICS, INC.SOLE | COM | 412.30K | SH | $4.70M 1.69% | 412.30K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS, INC.SOLE | COM | 139.73K | SH | $4.65M 1.68% | 139.73K | 0.00 | 0.00 |
PHARVARIS N. V.SOLE | COM | 244.28K | SH | $4.30M 1.55% | 244.28K | 0.00 | 0.00 |
DISC MEDICINE, INC.SOLE | COM | 74K | SH | $3.92M 1.41% | 74K | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS, INC.SOLE | COM | 2.63M | SH | $2.98M 1.07% | 2.63M | 0.00 | 0.00 |
GERON CORPSOLE | COM | 716K | SH | $1.01M 0.36% | 716K | 0.00 | 0.00 |
CIDARA THERAPEUTICS INCSOLE | COM NEW | 15K | SH | $730.6K 0.26% | 15K | 0.00 | 0.00 |
VYNE THERAPEUTICS INC.SOLE | COM | 317.03K | SH | $523.1K 0.19% | 317.03K | 0.00 | 0.00 |